Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Decision Making in R/R MM: What Options to Consider for 1st Relapse in Disease not Refractory to Lenalidomide, First Relapse in Lenalidomide-Refractory Disease, or After 2+ Prior Therapies?

0 views
January 11, 2021
Comments 0
Login to view comments. Click here to Login